Exosomal microRNAs as Central Regulators of Cancer Cachexia: Multi-Omics Insights into Muscle Wasting and Adipose Browning
Journal of Proteome Research · 2026
DOI: 10.1021/acs.jproteome.5c01051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Farman Matloob Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Bandar Puncak Alam 42300, Selangor Darul Ehsan, Malaysia. Hauptthemen laut MEDLINE: Cachexia, MicroRNAs, Exosomes, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 134 Literaturangaben.
Abstract (Originalsprache)
Cancer cachexia is a multifactorial syndrome marked by involuntary weight loss, skeletal muscle wasting, adipose tissue remodeling, and systemic metabolic dysfunction. Exosome-derived microRNAs (miRNAs) have emerged as key mediators, reprogramming host tissues and driving these hallmarks. However, no integrated framework has linked exosomal miRNAs to the proteomic and metabolomic alterations that characterize cachexia. This review critically synthesizes evidence on exosomal miRNAs in muscle atrophy, adipose browning, and systemic metabolic disruption. Tumor-secreted exosomal miRNAs activate proteolytic pathways (miR-21/29a via TLR7/8NF-κB/JNK), suppress antiapoptotic signals (miR-195a/125b targeting BCL-2), induce ER stress (miR-181a-3p), impair mitochondrial quality control (miR-122), and remodel metabolic signaling (miR-155, miR-183-5p). These mechanisms converge to produce proteomic signatures of enhanced proteolysis, apoptosis, and lipolysis, alongside metabolomic shifts toward amino acid efflux, fatty acid mobilization, and glycolytic inefficiency. This is the first integrated review linking exosomal miRNAs with proteomic and metabolomic signatures of cancer cachexia, offering a multiomics framework for biomarker discovery and therapeutic targeting. We highlight their potential as early biomarkers, therapeutic targets, and modulators of rehabilitation response, while outlining research gaps including limited clinical validation, intertumor heterogeneity, and the need for multiomics integration to advance translation into patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Bandar Puncak Alam 42300, Selangor Darul Ehsan, Malaysia.
- Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates.
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates.
- Department of Computer Science, Bahria University, Lahore 54000, Pakistan.
- Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates.
- Faculty of Pharmacy, Universiti Teknologi MARA Cawangan Pulau Pinang, Bertam Campus, 13200 Kepala Batas, Pulau Pinang, Malaysia.
ORCID-Profile: Farman Matloob Khan, Zahid Hussain
Zitieren
APA
Khan, F. M., El Awady, R., Mehmood, S., Hussain, Z., Othman, M. I., & Abdul Majeed, A. B. (2026). Exosomal microRNAs as Central Regulators of Cancer Cachexia: Multi-Omics Insights into Muscle Wasting and Adipose Browning. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c01051
Vancouver
Khan FM, El Awady R, Mehmood S, Hussain Z, Othman MI, Abdul Majeed AB. Exosomal microRNAs as Central Regulators of Cancer Cachexia: Multi-Omics Insights into Muscle Wasting and Adipose Browning. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.5c01051
BibTeX
@article{Khan2026,
author = {Khan, Farman Matloob and El Awady, Raafat and Mehmood, Shahid and Hussain, Zahid and Othman, Mohd Izani and Abdul Majeed, Abu Bakar},
title = {Exosomal microRNAs as Central Regulators of Cancer Cachexia: Multi-Omics Insights into Muscle Wasting and Adipose Browning},
journal = {Journal of Proteome Research},
year = {2026},
doi = {10.1021/acs.jproteome.5c01051}
}
EUVIMED